DRUG · COUNSELLING NOTES
Gilteritinib
XOSPATA
Updated
New prescription
indication: _____. daily, with/without food; report fever, dyspnea; warned on allergies; serious/common AEs: differentiation syndrome, QT prolongation, diarrhea; non-pharm: infection precautions
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; daily, with/without food; report fever, dyspnea; warned on allergies; serious/common AEs: differentiation syndrome, QT prolongation, diarrhea; non-pharm: infection precautions